Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Growth Metrics

Scientific Industries (SCND) Capital Expenditures (2016 - 2025)

Scientific Industries has reported Capital Expenditures over the past 16 years, most recently at $19600.0 for Q4 2025.

For Q4 2025, Capital Expenditures fell 14.41% year-over-year to $19600.0; the TTM value through Dec 2025 reached $63200.0, down 36.1%, while the annual FY2025 figure was $63200.0, 36.1% down from the prior year.
Capital Expenditures for Q4 2025 was $19600.0 at Scientific Industries, up from $10400.0 in the prior quarter.
Over five years, Capital Expenditures peaked at $594200.0 in Q2 2022 and troughed at $1500.0 in Q3 2022.
A 5-year average of $83706.7 and a median of $24700.0 in 2024 define the central range for Capital Expenditures.
Biggest five-year swings in Capital Expenditures: soared 2420.0% in 2021 and later plummeted 73.68% in 2023.
Year by year, Capital Expenditures stood at $163400.0 in 2021, then crashed by 99.08% to $1500.0 in 2022, then skyrocketed by 820.0% to $13800.0 in 2023, then surged by 65.94% to $22900.0 in 2024, then dropped by 14.41% to $19600.0 in 2025.
Business Quant data shows Capital Expenditures for SCND at $19600.0 in Q4 2025, $10400.0 in Q3 2025, and $6900.0 in Q2 2025.